Tag: TARGET BP

Ablative Solutions, Inc. Announces Enrollment Completion of TARGET BP I Study for Patients with Uncontrolled Hypertension

Coronary/Structural Heart by 0 comments

WAKEFIELD, Mass., April 12, 2023 /PRNewswire/ — Ablative Solutions, Inc., a company pioneering new approaches to the treatment of hypertension, today announced the completion of patient enrollment in the TARGET BP I Pivotal Study evaluating alcohol-mediated renal denervation with the Peregrine System. […]

Continue Reading →

Ablative Solutions Announces Enrollment and Randomization of First Patient in Global Clinical Trial Evaluating Company’s Novel Therapy for Uncontrolled Hypertension

Rhythm by 0 comments

SAN JOSE, Calif., July 23, 2019 /PRNewswire/ — Ablative Solutions, Inc., a company pioneering new approaches to the treatment of hypertension, today announced the enrollment and randomization of the first patient in the TARGET BP I global clinical trial. Piedmont Heart Institute […]

Continue Reading →